This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Blood Pressure Heart Failure Hypertension 
MIBHS
FEBRUARY 15, 2025
High blood pressure, also known as hypertension, is a common condition that affects millions of people worldwide. Often referred to as the silent killer, hypertension can quietly damage your heart and other vital organs over time. What Is High Blood Pressure?
American Heart News - Stroke News
SEPTEMBER 11, 2023
American Heart Association Hypertension Scientific Sessions – Abstract 452.
143 
DAIC
FEBRUARY 14, 2025
The retrospective analysis of data from the MODERATO II study demonstrated that AVIM therapy significantly improved echocardiographic (Echo) markers of diastolic dysfunction, an important component in the development of heart failure, in hypertensive patients. Advanced Heart Failure Cardiologist, Duke Health on Feb.
Cardiovascular Diabetology
AUGUST 11, 2024
We evaluated the prevalence of “heart stress” (HS) based on NT-proBNP cut-points proposed by the 2023 Consensus of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) in asymptomati.
111 
DAIC
FEBRUARY 27, 2024
milla1cf Tue, 02/27/2024 - 17:29 February 27, 2024 — Aria CV, Inc , a developer of medical devices treating pulmonary hypertension, today announced the first patient was implanted with the Gen 2 Aria CV Pulmonary Hypertension System as part of the ASPIRE PH clinical trial at Ascension St. Ashwin Ravichandran and Scott Hittinger.
110 
DAIC
JANUARY 19, 2024
The BACKBEAT pivotal study will evaluate the efficacy and safety of atrioventricular interval modulation (“AVIM”) therapy (also known as BackBeat CNT), for the treatment of pacemaker-indicated patients with uncontrolled hypertension despite the use of antihypertensive medications. Orchestra BioMed and Medtronic, Inc. Kowal, M.D.,
105 
DAIC
MAY 16, 2024
Getty Images milla1cf Thu, 05/16/2024 - 15:37 May 16, 2024 — People were more likely to develop a type of treatment-resistant hypertension when they experienced adverse effects of economic and social conditions that influence individual and group differences in health status, known as social determinants of health. Over a period of 9.5
105 
Cardiology Update
JULY 22, 2024
A study published in The Lancet reveals that targeting a systolic blood pressure of less than 120 mm Hg significantly reduces cardiovascular events in high-risk patients, compared to the standard target of less than 140 mm Hg. Key Findings – Blood Pressure Levels: The mean systolic blood pressure during follow-up was 119.1
MIBHS
OCTOBER 31, 2024
Both forms of enlargement may compromise the heart’s ability to pump blood efficiently, leading to further complications like heart failure. What Causes an Enlarged Heart? High Blood Pressure (Hypertension) Persistent high blood pressure forces the heart to work harder to pump blood.
CardiacWire
AUGUST 23, 2024
It looks like we might be able to add prediabetes and hypertension to the growing list of conditions that Eli Lilly’s “weight loss drug” tirzepatide is able to treat, after new analysis of the SURMOUNT-1 trial showed significant reductions in blood pressure and diabetes progression. mm Hg systolic and 4.2 of placebo-takers.
64 
Hypertension Journal
DECEMBER 5, 2024
Hypertension, Ahead of Print. BACKGROUND:Orthostatic hypertension is an emerging risk factor for adverse events. These differences in CVD risk raise important concerns about combining systolic orthostatic increases and standing SBP 140 mm Hg in a consensus definition for orthostatic hypertension.
Hypertension Journal
MAY 8, 2024
Hypertension, Ahead of Print. Epidemiological studies have revealed that hypertensive heart disease is a major risk factor for heart failure, and its heart failure burden is growing rapidly.
Journal of the American Heart Association
MARCH 17, 2025
Intensive blood pressure (BP) lowering can reduce cardiovascular events and allcause mortality, but its benefits for patients with hypertension with multiple comorbidities are uncertain. MethodsWe analyzed data from the SPRINT data set and calculated each patient's comorbidity score using the Charlson Comorbidity Index (CCI).
Medical Xpress - Cardiology
MARCH 4, 2025
In the 1980s, when Stella Kourembanas, MD, began her career in neonatology, she cared for newborns with pulmonary hypertension, a disease that results in abnormally high blood pressure in the lung arteries and can lead to heart failure. But pulmonary hypertension still persists.
47 
DAIC
JUNE 18, 2024
A projected rise in heart disease and stroke – along with several key risk factors, including high blood pressure and obesity – is likely to triple related costs to $1.8 trillion by 2050, according to two American Heart Association ( AHA ) presidential advisories published June 4 in the AHA journal Circulation.
105 
Hypertension Journal
OCTOBER 10, 2023
Hypertension, Volume 80, Issue 12 , Page 2572-2580, December 1, 2023. BACKGROUND:The STEP (Strategy of Blood Pressure Intervention in the Elderly Hypertensive Patients) trial demonstrated that intensive systolic blood pressure (SBP) lowering has cardiovascular benefits. years, and 46.5% years, and 46.5%
Dr. Smith's ECG Blog
MAY 20, 2024
A 63 year old man with a history of hypertension, hyperlipidemia, prediabetes, and a family history of CAD developed chest pain, shortness of breath, and diaphoresis after consuming a large meal at noon. He called EMS, who arrived on scene about two hours after the onset of pain to find him hypertensive at 220 systolic.
125 
Hypertension Journal
JANUARY 2, 2024
Hypertension, Ahead of Print. Using Cox proportional hazards regression, we tested interactions between history of cancer and intensive blood pressure control on major cardiovascular outcomes.RESULTS:The study included a total of 9336 patients, with a mean age of 67.9±9.4 years, among whom 2066 (22.2%) were cancer survivors.
DAIC
AUGUST 21, 2024
21, 2024 — The incidence rate of heart failure was 2- to 3-fold higher among American Indian populations than rates observed in studies focused on other population groups, such as African American, Hispanic or white adults, in a new study published in the Journal of the American Heart Association.
Circulation
NOVEMBER 11, 2024
Background:Stage B heart failure (HF) was associated with increased cardiovascular and HF events. Hypertension is a risk factor for these events in Stage B HF. Circulation, Volume 150, Issue Suppl_1 , Page A4139510-A4139510, November 12, 2024.
DAIC
FEBRUARY 28, 2024
The findings – published this week in the Journal of the American College of Cardiology — could fuel advocacy for a paradigm shift in clinical heart health guidelines to address cardiovascular risk factors at an earlier age in childhood cancer survivors.
105 
Heart BMJ
DECEMBER 20, 2023
Hypertension is the single most important risk factor for development of atrial fibrillation (AF), which may be considered as a cardiac manifestation of hypertensive target organ damage. Furthermore, coexistence of hypertension and AF mutually amplifies the risk of complications, such as heart failure and stroke.
Hypertension Journal
DECEMBER 11, 2023
Hypertension, Ahead of Print. BACKGROUND:The long-term benefit of achieving the Japanese Society of Hypertension home systolic blood pressure (SBP) target of <125 mm Hg has not been fully evaluated. 2.00] for overall cardiovascular disease and 2.68 [95% CI, 1.34–5.38]
Circulation
OCTOBER 13, 2023
BACKGROUND:Apparent treatment-resistant hypertension (aTRH) is prevalent and associated with adverse outcomes in heart failure with mildly reduced or preserved ejection fraction. Nonresistant hypertension was defined as BP above threshold but not meeting aTRH criteria. Controlled BP was defined as BP under threshold.
Dr. Paddy Barrett
AUGUST 9, 2024
The 14 Factors Include: Hearing Loss High LDL cholesterol Less Education Traumatic Brain Injury Depression Social Isolation Hypertension Obesity Smoking Excess Alcohol Diabetes Physical Inactivity Air Pollution Visual Loss Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission When You Intervene Matters.
115 
Journal of the American Heart Association
MARCH 13, 2025
The CRHCP (China Rural Hypertension Control Project) trial demonstrated that intensive BP control reduces cardiovascular events. The primary outcome of major adverse cardiovascular events included stroke, myocardial infarction, heart failure, and death from cardiovascular causes, during a 3year followup.
Frontiers in Cardiovascular Medicine
FEBRUARY 13, 2024
Introduction Angiotensin receptor-neprilysin inhibitor (ARNi), comprised of an angiotensin receptor blocker (ARB) and a neprilysin inhibitor (NEPi), has established itself as a safe and effective intervention for hypertension. S086 is a novel ARNi cocrystal developed by Salubris for the treatment of heart failure and hypertension.
49 
HeartRhythm
APRIL 30, 2024
Introduction: Patients with ‘heart failure with preserved ejection fraction’ (HFpEF) frequently manifest chronotropic incompetence as well as hypertension (HTN). Cardiac pacing may improve clinical outcomes in these patients. To date, pacing has not been regulated by an external hemodynamic input.
Hypertension Journal
FEBRUARY 22, 2024
Hypertension, Ahead of Print. Blood pressure is regulated by vascular resistance and intravascular volume. Here, we describe the anatomy and function of the lymphatic system and focus on its plasticity in relation to the accumulation of interstitial sodium in hypertension.
40 European Journal of Heart Failure
DECEMBER 10, 2024
Aims Patients experiencing ischaemic heart failure with reduced ejection fraction (HFrEF) represent a diverse group. Aims Patients experiencing ischaemic heart failure with reduced ejection fraction (HFrEF) represent a diverse group. Clusters were identified using both clinical and biological variables.
Hypertension Journal
JANUARY 13, 2025
Hypertension, Ahead of Print. BACKGROUND:Blood pressure (BP) time in target range (TTR) reflects the proportion of time that BP measurement is within a specified target range. We aim to summarize the evidence for relationships between TTR and adverse health outcomes.METHODS:Seven databases were searched.
Circulation
NOVEMBER 11, 2024
Introduction:High levels of blood pressure (BP) are responsible for 7.6 The diagnosis of hypertension is associated with a significant increase in the risk of kidney or cardiovascular events, with no prior history of these events. The AAMR for hypertensive heart and renal disease with heart failure was 0.1
40 
Wellnest
FEBRUARY 28, 2023
Insufficient or interrupted sleep can affect blood pressure and increase the risk of heart attacks, stroke, diabetes, and other cardiovascular diseases. High blood pressure and heart disease are related to insomnia. Sleep Issues Are Caused by Heart Failure Heart failure complications may impact your sleep.
Hypertension Journal
FEBRUARY 22, 2024
Hypertension, Ahead of Print. Background:We tested the hypothesis that patients with heart failure with preserved ejection fraction (HFpEF) would have greater muscle sympathetic nerve activity (MSNA) at rest and sympathetic reactivity during a cold pressor test compared with non–heart failure controls.
MIBHS
JULY 31, 2024
Here are some of the major ways in which chronic stress negatively impacts cardiovascular health: High Blood Pressure When you experience stress, your body releases hormones like cortisol and adrenaline, which cause your heart rate and blood pressure to spike.
Circulation: Heart Failure
MARCH 5, 2025
Circulation: Heart Failure, Ahead of Print. BACKGROUND:Exercise-induced hypertension (EIH) is common in adults with coarctation of the aorta (COA), but there are limited data about hemodynamics and outcomes in such patients.
40 Hypertension Journal
JANUARY 16, 2025
Hypertension, Ahead of Print. BACKGROUND:Adrenomedullin 2 (AM2) plays critical roles in regulating blood pressure and fluid balance. Comprehensive cardiac morphology, function, histology, and transcriptome/metabolome analyses were conducted.
45 
Circulation
NOVEMBER 11, 2024
Intro:Drug Development for Heart failure with Preserved Ejection Fraction (HFpEF) is a major challenge facing cardiovascular research due to its complex pathophysiology and existence of comorbidities, leading to recognize distinct HFpEF phenogroups. Cardiac hypertrophy was confirmed by increased heart weight (p<0.01
DAIC
FEBRUARY 29, 2024
ET Main Tent (Hall B1) Effect of Gamification, Financial Incentives or Both Combined to Increase Physical Activity Among Patients with Elevated Risk For Major Adverse Cardiovascular Events.
103 
Open Heart
JUNE 1, 2022
to 1.17), higher mean systolic blood pressure (OR 1.03, 95% CI 1.02 to 1.05) and higher mean diastolic blood pressure (OR 1.03, 95% CI 1.01 In a multivariable model including age, duration on ART, body mass index, and systolic and diastolic blood pressure, only mean body mass index (adjusted OR 1.10, 95% CI 1.02
AMS Cardiology
AUGUST 15, 2023
Family history – If a close family member has had heart disease, it can raise your risk. High blood pressure – Hypertension is a significant risk factor for heart disease. Routine blood pressure checks are essential to maintaining a healthy heart as high blood pressure often has no symptoms.
Journal of the American Heart Association
FEBRUARY 26, 2025
We previously demonstrated that IL17A promotes neuroinflammation and sympathetic excitation, contributing to cardiac dysfunction in heart failure and angiotensin II (ANG II)induced hypertension.
Cardiometabolic Health Congress
NOVEMBER 16, 2023
MIRROR trial supports urate-lowering agent for gout and uncontrolled hypertension. Data from the MIRROR trial showed that the use of pegloticase plus methotrexate was associated with more significant reductions in systolic blood pressure compared to pegloticase alone in patients with gout and uncontrolled hypertension.
Dr. Smith's ECG Blog
OCTOBER 20, 2024
Written by Magnus Nossen The patient in today's case is a male in his 70s with hypertension and type II diabetes mellitus. On arrival in the emergency department, invasive blood pressure was 35/15mmHg and the patient was in profound cardiogenic shock with severe confusion secondary to brain hypoperfusion. PUSH THE LYTICS !
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content